Simplex Trading
DICE

Simplex Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Simplex Trading’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,300
Closed -$943K – 10307
2023
Q2 		$943K Buy
20,300
+3,600
+22% +$124K ﹤0.01% 2655
2023
Q1 		$478K Buy
16,700
+800
+5% +$23.7K ﹤0.01% 3317
2022
Q4 		$496K Buy
15,900
+14,200
+835% +$463K ﹤0.01% 3166
2022
Q3 		$34K Buy
+1,700
New +$31K ﹤0.01% 6943

Simplex Trading's DICE Position: Q3 2023 in Review

Simplex Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 4,062 shares — an estimated $188K sold.

Simplex Trading first reported a position in DICE in Q1 2022 and held it in 5 quarters. The position peaked at $228K in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Simplex Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 4,062 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $188K.
  • Simplex Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Simplex Trading's DICE Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.